R&D Changing Faces: Pharma and biotech hires, May 2026 Looking back to May, the pharma and biotech sector saw a steady stream of senior leadership changes.
News Tarek Samad takes on task of delivering on Lundbeck's R&D Lundbeck names Tarek Samad to replace its retiring R&D chief, Johan Luthman, and he is facing a tough task as the firm heads towards a patent cliff.
News Sanofi names ex-Roche exec Fontoura as R&D chief Paulo Fontoura, currently chief medical officer of Xaira Therapeutics, will replace Houmab Ashrafian as Sanofi's R&D head on 1st September.
News Pushy NHS chatbots 'can put patients off screening' Amid the push to digitise the UK health service, a study has sounded a note of caution about entrusting important patient appointments to chatbots.
News Jen Norton appointed market access leader at EVERSANA EVERSANA has named Jen Norton as president of its recently formed Market Access & Value division.
R&D Changing Faces: Boards of Directors and Advisory Boards – Ap... Boardrooms and advisory panels across biotech, pharma, digital health, and life sciences suppliers saw a wave of high‑profile additions in April.
News Despite study bust, Vistagen still hopes to file anxiety dru... Vistagen has chalked up another trial failure for fasedienol, its drug candidate for social anxiety disorder.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
